133 related articles for article (PubMed ID: 30732964)
21. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
[TBL] [Abstract][Full Text] [Related]
22. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
[TBL] [Abstract][Full Text] [Related]
23. Death from thyroid cancer of follicular cell origin.
Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
[TBL] [Abstract][Full Text] [Related]
24. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
Lang B; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
[TBL] [Abstract][Full Text] [Related]
25. Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.
Kim HI; Kim K; Park SY; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Ahn HS; Kim SW; Kim TH; Chung JH
Oral Oncol; 2018 Mar; 78():80-86. PubMed ID: 29496063
[TBL] [Abstract][Full Text] [Related]
26. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
27. The effects of the Union for International Cancer Control/American Joint Committee on Cancer Tumour, Node, Metastasis system version 8 on staging of differentiated thyroid cancer: a comparison to version 7.
Verburg FA; Mäder U; Luster M; Reiners C
Clin Endocrinol (Oxf); 2018 Jun; 88(6):950-956. PubMed ID: 29573277
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract][Full Text] [Related]
29. TNM 8th edition in thyroid cancer staging: is there an improvement in predicting recurrence?
Manzardo OA; Cellini M; Indirli R; Dolci A; Colombo P; Carrone F; Lavezzi E; Mantovani G; Mazziotti G; Arosio M; Lania AGA
Endocr Relat Cancer; 2020 Jun; 27(6):325-336. PubMed ID: 32229701
[TBL] [Abstract][Full Text] [Related]
30. Depicting distant metastatic risk by refined subgroups derived from the 8th edition nasopharyngeal carcinoma TNM.
Guo Q; Lu T; Hui Huang S; O'Sullivan B; Zong J; Xiao Y; Xu W; Chen C; Qiu S; Xu L; Zheng W; Chen Y; Lin S; Pan J
Oral Oncol; 2019 Apr; 91():113-120. PubMed ID: 30926056
[TBL] [Abstract][Full Text] [Related]
31. Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.
Verburg FA; Mäder U; Tanase K; Thies ED; Diessl S; Buck AK; Luster M; Reiners C
J Clin Endocrinol Metab; 2013 Jan; 98(1):172-80. PubMed ID: 23150687
[TBL] [Abstract][Full Text] [Related]
32. Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.
Mankarios D; Baade P; Youl P; Mortimer RH; Onitilo AA; Russell A; Doi SA
Endocrine; 2014 Jun; 46(2):300-8. PubMed ID: 24174176
[TBL] [Abstract][Full Text] [Related]
33. Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations.
Kim TH; Ki CS; Kim HS; Kim K; Choe JH; Kim JH; Kim JS; Oh YL; Hahn SY; Shin JH; Jang HW; Kim SW; Chung JH
J Clin Endocrinol Metab; 2017 May; 102(5):1757-1764. PubMed ID: 28323925
[TBL] [Abstract][Full Text] [Related]
34. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
35. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the 8
Ito Y; Miyauchi A; Hirokawa M; Yamamoto M; Oda H; Masuoka H; Sasai H; Fukushima M; Higashiyama T; Kihara M; Miya A
Endocr J; 2018 Jul; 65(7):707-716. PubMed ID: 29681581
[TBL] [Abstract][Full Text] [Related]
38. Impact of the change from the seventh to eighth edition of the AJCC TNM classification of malignant tumours and comparison with the MACIS prognostic scoring system in non-medullary thyroid cancer.
Dwamena S; Patel N; Egan R; Stechman M; Scott-Coombes D
BJS Open; 2019 Oct; 3(5):623-628. PubMed ID: 31592514
[TBL] [Abstract][Full Text] [Related]
39. Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non-small-cell Lung Cancer.
Chen K; Chen H; Yang F; Sui X; Li X; Wang J
Clin Lung Cancer; 2017 Nov; 18(6):e457-e466. PubMed ID: 28539214
[TBL] [Abstract][Full Text] [Related]
40. The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Lee VH; Kwong DL; Leung TW; Choi CW; O'Sullivan B; Lam KO; Lai V; Khong PL; Chan SK; Ng CY; Tong CC; Ho PP; Chan WL; Wong LS; Leung DK; Chan SY; So TH; Luk MY; Lee AW
Int J Cancer; 2019 Apr; 144(7):1713-1722. PubMed ID: 30192385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
